Recruiting Ovarian Cancer Studies in Minneapolis
Relacorilant in Combination With Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
This is a Phase 2, single-arm, open-label study to evaluate efficacy and safety of intermittent dosing of relacorilant in combination with nab-paclitaxel and bevacizumab in patients with ovarian cance...
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
The proposed study design is a single arm Phase II trial to document the feasibility of carboplatin-mirvetuximab - in patients with advanced-stage EOC. Patients with biopsy confirmed, newly diagnosed,...
About Ovarian Cancer Clinical Trials in Minneapolis
Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.
There are currently 2 ovarian cancer clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 160 participants. Research is being sponsored by Corcept Therapeutics, University of Alabama at Birmingham. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ovarian Cancer Clinical Trials in Minneapolis — FAQ
Are there ovarian cancer clinical trials in Minneapolis?
Yes, there are 2 ovarian cancer clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What ovarian cancer treatments are being tested?
The 2 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.
Data updated March 2, 2026 from ClinicalTrials.gov